top of page

NEUROCYTONIX

Repairing the Brain

NeuroCytonix is an emerging biomedical technology company founded in January 2017 to develop transformational medical technologies for regeneration of the nervous system.

Home: Welcome

REGROWING THE BRAIN

Currently we are conducting a double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of the NeuroCytotron in patients with cerebral palsy.

Home: About
Neuron field.jpg
Drawing-on-board_edited.jpg

J. Roberto Trujillo, an MD and PhD from Harvard University, has worked on clinical and basic neuroscience research for over 25 years. He is the founder of NeuroCytonix.

​

More about Dr. Trujillo

NeuroCytonix technology and its related protocols are a new approach to the treatment of non-progressive neurodegenerative diseases such as stroke, cerebral palsy and traumatic brain injury.

in%2520machine_edited_edited.png

First FDA controlled clinical trial for cerebral palsy currently in process.

​

link to NeuroCytonix clinical trial information in ClinicalTrials.gov

Our cutting-edge technology
neuron tissue engineering

machine.png

NeuroCytonix has structured a team of 20 specialists in Monterrey, Mexico for cerebral palsy clinical trials.

Home: Recent News

CONTACT US

Thanks for submitting!

Home: Contact
bottom of page